Close menu




news.financial


Commented by Fabian Lorenz on October 27th, 2026 | 05:43 CET

Almonty Makes History! Will BASF Bid More for Evonik? Is tonies a Buy?

  • raw materials
  • chemicals
  • toys
  • technology

It is an upside-down world at Almonty at present. While its share price has halved in recent months, the tungsten producer is making operational history. For the first time in more than 30 years, a shipment of tungsten from the Sangdong mine in South Korea has been dispatched. Monthly shipments of around 200 tonnes of the critical raw material are expected to follow soon. Analysts forecast a sharp increase in earnings to USD 2.76 per share next year. The share is currently trading below USD 10. BASF, by contrast, may not be a bargain. The company wants to acquire Evonik and could increase its offer. Although analysts view the plan more positively, they remain cautious about the shares. Meanwhile, analysts recommend tonies as a Buy. Expectations for the upcoming results have risen following a 20% rally, but analysts anticipate strong growth.

Read

Commented by Lars Winter on October 27th, 2026 | 05:42 CET

Desert Gold Poised for a Breakout, Adidas and Deutsche Börse Issue New Forecasts: Three Stocks in Focus

  • Gold
  • Gold price
  • Precious metals
  • Desert Gold
  • Adidas
  • Deutsche Börse

Created and Published on Behalf of Desert Gold Ventures Inc.

Although the gold price has recently corrected sharply, Desert Gold shares may be approaching a longer-term uptrend. In Mali, the promising gravity processing plant is reportedly set to be commissioned soon. Initial gold production could mark a turning point for the company. Adidas, meanwhile, has reported record figures, and Deutsche Börse has raised its forecast once again. Three stocks with strong share price drivers, but very different opportunities and risks. We take a closer look at the trio in our stock review.

Read

Commented by Jens Castner on October 27th, 2026 | 05:38 CET

Environmental Liabilities as a Goldmine: Zefiro Methane Builds a Strong Order Book, Analysts See 200% Upside

  • Climate protection
  • Methane
  • Capital increases
  • CO2 emissions
  • Undervaluation
  • Zefiro Methane

Created and published on behalf of Zefiro Methane Corp.

Investors subscribing to new share issues normally expect a discount. At Zefiro Methane, however, investors were willing to pay more than the stock's market price. The market promptly responded to this vote of confidence by pushing the share price higher. The order books of the Canadian specialist in remediating environmentally hazardous oil and gas wells are filled through 2029, and its price-to-earnings (P/E) ratio stands at around 11. GBC Research analysts see more than 200% upside potential.

Read

Commented by Stefan Feulner on October 27th, 2026 | 05:36 CET

Siemens Energy, RE Royalties and Nordex – 30 Years That Have Investors Taking Notice

  • renewable energy

A 30-year maintenance contract for new wind turbines. Ten years of additional revenue, even though a loan has already been repaid in full. And 120 new switchgear panels for one of Germany's most important power grids. These figures represent more than just another set of orders from the energy sector. They show how companies are seeking to turn one-off investments into predictable long-term revenue streams. For investors, this development could prove more significant than the sheer number of newly installed megawatts.

Read

Commented by Tarik Dede on October 27th, 2026 | 05:35 CET

Uranium Stocks with Potential: Standard Uranium, Energy Fuels and Cameco in Focus

  • Uranium
  • Nuclear energy
  • Nuclear power
  • Cameco
  • StandardUranium
  • EnergyFuels
  • RareEarths

A total of 415 nuclear reactors are currently operating in 31 countries, with another 72 under construction, according to industry studies. Countries such as China, India, Russia and Türkiye are relying on nuclear power to meet their energy needs. In the US and Belgium, older reactors are also being brought back online. Demand for uranium should therefore continue to rise in the coming years and decades. While uranium prices have remained relatively firm on the spot market, although this is not a particularly reliable indicator, uranium stocks are currently falling sharply. The Global X Uranium ETF reached a new 52-week low just a few days ago. Accordingly, this sell-off offers bold, long-term investors an opportunity to build positions. Today, we take a closer look at Cameco, Standard Uranium and Energy Fuels.

Read

Commented by André Will-Laudien on October 27th, 2026 | 05:34 CET

Strong Stock Gains from the Green Transition! How Coca-Cola, Bayer, MustGrow and PepsiCo Are Preparing for the Future

  • Food & Berverage
  • Sustainability
  • CropScience
  • BioTech
  • AgriTech

Created and Published on Behalf of MustGrow Biologics Corp.

Despite regulatory progress, global food security remains precarious. According to a recent report by Welthungerhilfe and partner organisations, around a tenth of the world's population suffers from acute malnutrition. Global crises such as climate change and armed conflicts are further exacerbating the situation. Large corporations must therefore go beyond statutory minimum standards and guarantee fair purchase prices to strengthen the resilience of smallholder farms. Only by firmly linking corporate due diligence with sustainable farming practices can the UN Sustainable Development Goal of ending hunger be achieved in the long term. To steer multinational corporations' market power toward more sustainable practices, the European Union is increasingly turning to regulation. A key instrument is the EU Corporate Sustainability Due Diligence Directive (CSDDD), which, from 2026, is intended to require comprehensive compliance with human rights and environmental standards throughout the value chain. Large agricultural and food companies must therefore demonstrate that their suppliers do not destroy local livelihoods, such as access to clean drinking water or fertile land. For investors, these developments are creating a range of opportunities around an emerging megatrend. Allocating a portion of a portfolio to the food, beverage and crop science sectors may therefore make sense.

Read

Commented by Jens Castner on October 27th, 2026 | 05:25 CET

The Market Is Asleep, but Analysts Are Bullish: LVMH, dynaCERT and Mercedes-Benz with Up to 650% Upside

  • Luxury
  • Logistics
  • Automobiles
  • Consumption
  • Diesel engines
  • E-mobility
  • LVMH
  • dynaCERT
  • Mercedes-Benz
  • Analysts
  • Quarterly results
  • Dividends
  • Climate protection
  • CO2 emissions

Analysts recommend buying, but share prices are going nowhere. Despite ambitious price targets, LVMH, dynaCERT and Mercedes-Benz are struggling to gain ground. At the French luxury goods group, even the CEO is buying shares, while the Stuttgart-based automaker offers an enticing 7.5% dividend yield. dynaCERT has the largest gap between its share price and its target price. Analysts see 650% upside potential for the Canadian specialist in fuel-saving diesel technology. What is holding the trio back, and what could get their share prices moving again? Read on to find out.

Read

Commented by Armin Schulz on October 27th, 2026 | 05:21 CET

Pharma Stocks with a Future: Bayer, BioNxt Solutions and Novo Nordisk Expand Their Pipelines

  • Bayer
  • BioNxt Solutions
  • Novo Nordisk
  • Investments
  • Active ingredients
  • Dosage forms
  • Thin film
  • Orally disintegrating film
  • Cladribine
  • Diabetes
  • Obesity
  • Weight-loss pill

No pharmaceutical company can rely on its bestsellers forever. Eventually, patent protection expires, generic manufacturers enter the market, and margins come under pressure. Companies that fail to replenish their product pipelines risk being left behind. That is why substantial sums are currently flowing into new active ingredients, manufacturing facilities and innovative drug delivery methods. Bayer plans to invest USD 2.2 billion in a pharmaceutical plant in Ohio. Smaller developers such as BioNxt Solutions are exploring new formulations and delivery methods for established active ingredients. At the end of September, Novo Nordisk agreed to license an oral drug candidate, including an upfront payment of USD 300 million. We take a closer look at Bayer, BioNxt Solutions and Novo Nordisk.

Read

Commented by Stefan Bode on October 27th, 2026 | 05:20 CET

Crucial Tests Ahead – Airbus, HPQ Silicon and Singulus

  • Airbus
  • HPQ Silicon
  • Singulus

Created and published on behalf of HPQ Silicon

Geopolitical tensions, supply chain constraints and the transformation of entire industries are reshaping markets. An established major European company is benefiting from robust demand and is delivering more units than its North American competitor. Meanwhile, a materials technology specialist and a plant manufacturer face the challenge of demonstrating that their operational progress is sustainable over the long term and generates revenue. This report examines the key metrics, risks and technical chart levels that could become relevant to the future performance of these stocks.

Read

Commented by Fabian Lorenz on October 26th, 2026 | 05:44 CET

Chart alert and buy recommendation! SMA Solar, Nordex and RE Royalties

  • Energy
  • solar
  • wind

Chart alert and buy recommendation for SMA Solar. The shares are threatening to break below their sideways trading range, yet analysts see higher prices as justified. Could the quarterly results turn things around? RE Royalties has recently reported positive developments. The renewable energy royalty specialist has secured new projects and received a sizeable repayment. The company is also reviewing strategic options that could lead to a takeover. Nordex continues to benefit from favourable operating conditions. Following positive preliminary figures and buy recommendations from analysts, the wind turbine manufacturer has followed up with an order from a new country. Nevertheless, its shares continue to weaken.

Read

Commented by Nico Popp on October 26th, 2026 | 05:43 CET

Lahontan Gold, Kinross Gold and Barrick Mining: Strong Position in Nevada

  • Gold
  • Nevada
  • Heap leaching
  • Feasibility study
  • Takeover

The gold market is currently experiencing high volatility. The precious metal fell about 6% in a month and recently slipped below USD 4,000 per ounce for the first time since July. The long-term outlook remains robust according to a forecast by Goldman Sachs, with an expected price of USD 5,400 by the end of 2027. Against this backdrop, mining companies in Nevada are repositioning themselves. While established industry heavyweights are optimising their production, developers are advancing their projects towards production. One such company is Lahontan Gold.

Read

Commented by Stefan Bode on October 26th, 2026 | 05:38 CET

Figures, Risks and Opportunities: Mensch und Maschine, Nordex, Strategic Resources

  • Mensch und Maschine
  • Nordex
  • Strategic Resources

In today's markets, strong headlines alone are not enough; the quality of the figures and a company's ability to meet market expectations are equally important. Three very different stocks illustrate how quickly market sentiment can shift. While one stock's technical support is faltering, new growth projects are fuelling optimism for another. A third is benefiting from a marked improvement in operational performance, although its next technical hurdle is already looming.

Read

Commented by Carsten Mainitz on October 26th, 2026 | 05:29 CET

Share prices are falling, business is growing: What opportunities do Almonty, Rheinmetall and Renk shares offer investors?

  • Tungsten
  • Critical raw materials
  • Military
  • Armaments
  • Defence
  • Supply chains
  • Geopolitics

The euphoria has apparently faded. Following sharp share price declines, Almonty, Rheinmetall and Renk are increasingly back in focus. With demand trends intact, are these new entry opportunities? After all, without raw materials there is no ammunition; without drive systems there are no mobile armed forces. Almonty has commenced commercial operations at the Sangdong tungsten mine, marking a historic milestone. Rheinmetall and Renk are under scrutiny for how quickly and profitably they can fulfil orders. Wait or buy?

Read

Commented by Armin Schulz on October 26th, 2026 | 05:27 CET

Shell, Zefiro Methane and BP: Oil Stocks Ahead of Earnings, Legacy Wells Create Opportunities for Specialists

  • Shell
  • Zefiro Methane
  • BP
  • Oil
  • Gas
  • Methane
  • Methane measurements
  • Wells
  • Carbon Credits
  • Emissions

Created and published on behalf of Zefiro Methane Corp.

Shell and BP are due to report their third-quarter results next week, with Shell scheduled for October 29 and BP for the following day. Both groups have already briefed investors on the quarter. But production and refining margins are only half the story. The oil industry also leaves behind legacy liabilities, from methane leaks to orphaned wells. Policymakers are paying closer attention, although on October 22 the European Parliament postponed methane reporting requirements for importers of oil, gas and coal until the end of May 2031. This creates work for specialists tasked with addressing the problem. We take a closer look at Shell, Zefiro Methane and BP.

Read

Commented by Tarik Dede on October 26th, 2026 | 05:25 CET

AI dominates the markets: Meta, Aspermont and SanDisk in focus

  • Meta
  • Aspermont
  • Sandisk
  • AI
  • Data

Volatility on US stock markets remains extremely high! AI stocks in particular are in the spotlight, as more and more investors and analysts cannot see how the significant investments in AI data centres are supposed to pay off in the long term. Meanwhile, the indices have become heavily weighted towards AI. As the well-known fund manager and asset manager Jens Ehrhardt recently noted, two-thirds of S&P 500 earnings growth currently depends on two stocks: Nvidia and Micron. Either way, even difficult periods offer opportunities in hyped stocks. Nevertheless, investors must also recognise the risks. That is why today we are looking at Meta, Aspermont and SanDisk shares.

Read